MCK · McKesson Corp

NYSE Health Care Large Cap Clavix B+
912.90−8.48  (−0.92%)

Price

Snapshot

50 fields · last close
Market Cap$107.4B
P/E23.40
Float117.0M
Beta0.30
Volatility7.5%
ExchangeNYSE
SectorHealth Care
Cap tierLarge cap
Macro sensitivityLow
Clavix score78
Price912.90
Change−0.92%
Prev Close921.38
Open924.89
Day Low916.14
Day High929.95
Avg Vol1
Avg $ Vol$868.2M
52W High999.00
52W Low682.35
52W Pos72.8%
From High−8.62%
From Low+33.79%
Max DD 1Y−27.17%
Spread0.10%
LiquidityDeep
SMA 20+3.54%
SMA 50+8.12%
SMA 200+8.30%
RSI (14)63.0
Vol 30D34.4%
Vol 90D31.6%
1Y Range682–999
Daily bars506
Perf Week+3.47%
Perf Month+5.03%
Perf Quarter+21.72%
Perf Half Y−1.07%
Perf Year+33.37%
Perf YTD+10.86%
Prev Day−0.92%
ClavixB+
Debt / Eq1.45
Curr Ratio0.85
Int Cover29.8×
FCF Margin1.7%
Rev Growth+7.7%
ProfitProfitable
LeverageModerate
Sector rank19 / 47

What MCK does

McKesson Corporation provides healthcare services in the United States and internationally.

It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.

The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers.

It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care.

In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies.

Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers.

McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Clavix risk grade

regraded every trading day
B+78/100

MCK grades B+, 78 of 100. Steadiest on Sector Resilience (67), most exposed on News Sentiment (49, fragile). 2 of the 4 weighted dimensions sit above the Health Care median. Ranks 19 of 47 in Health Care by Clavix score.

PriceMacroSectorNewsFinancial

How rough the ride is

MCKHealth Care median
Betavs the overall market · lower is steadier0.300.81
Volatilityannualized7.5%20.4%
Max drawdown, past yearworst peak-to-trough fall−27.2%
Typical daily movemedian absolute daily change1.03%
Days beyond ±3%of the last 252 sessions177%

How its days are spread

Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.

52-week range

MCK
921.38

The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.

Drawdown from the 1-year peak

MCK

Percent below the running high over the last 12 months. Zero is a fresh high.

Market sensitivity

MCKHealth Care median
Beta to the markethow much it swings with the S&P 500 · lower is safer0.300.81
Macro sensitivityrate, dollar and credit exposure bucketLowModerate55% of 47

Where it sits on the macro scale

Low 11Moderate 26High 7Very High 3

Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.

Where it ranks in its sector

Sector
Health Care47 companies ranked
MCK
#19 of 47

Rank by Clavix score within the sector. Right is the top of the sector.

Price performance

MCK
1 week+3.5%
1 month+5.0%
Year to date+10.9%
1 year+33.4%

Context for the rank, not itself a risk measure.

Recent coverage, scored

MCK
Articles scoredthe most recent scored coverage, up to 3030since 11 Jul
Average score0 most bearish, 100 most bullish60
Bullish · bearisharticles above 60 · below 4019 · 6
Directionarticles whose tone is improving vs worsening19 ↑ 6 ↓

Where the article scores land

Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.

Balance sheet, against the sector

Debt / equityTotal debt vs shareholder equity · lower is stronger
1.45sector median 0.71 · 47 names
Current ratioShort-term assets vs liabilities · higher is stronger
0.85sector median 1.58 · 47 names
FCF marginFree cash flow as a share of revenue · higher is stronger
1.7%sector median 8.6% · 45 names
Interest coverageOperating income vs interest expense · higher is stronger
29.8×sector median 6.3× · 42 names

The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.

Growth

MCK
Revenue growthyear over year+7.7%

Financial Health is shown but does not count toward the grade. Why

0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.

Against Health Care

47 companies
MetricMCKSector spreadMedian
Beta0.30
0.81
Volatility7.5%
20.4%
P/E23.40
26.14
Debt / equity1.45
0.71
Current ratio0.85
1.58
FCF margin1.7%
8.6%
Interest coverage29.8×
6.3×

Recent news

most recent scored articles · the chip is the article’s score · click to open

A hacking group claims to have stolen millions of patient health records during a cyberattack on McKesson, a major U.S. pharmaceutical distribution company, last week.

Source TechCrunch Significance major Impact regulatory Risk worsening

Read the article →

McKesson has agreed to buy privately held Precision Medicine Group for about $2.25 billion. Precision Medicine provides clinical research, laboratory testing, and services that help biotech and pharmaceutical companies launch new medicines.

Source yahoo.com Significance moderate Impact financial impact Risk improving

Read the article →

Law firm Ademi LLP announced it is investigating potential data privacy claims against McKesson related to a data breach, examining whether the company maintained reasonable safeguards to protect personal information.

Source globenewswire.com Significance moderate Impact regulatory Risk worsening

Read the article →

McKesson has disclosed a cybersecurity incident where someone gained unauthorized access to third-party applications used by the company and stole data. The extortion group ShinyHunters is claiming responsibility and says it took 284 million patient records.

Source databreaches.net Significance moderate Impact regulatory Risk worsening

Read the article →

McKesson told the SEC that it had a cybersecurity incident and that an investigation is in the early stages. The company said the impact has not yet been determined to be material.

Source gurufocus.com Significance minor Impact regulatory Risk worsening

Read the article →

Nearest peers by size

Health Care
TickerCompanyGradeMkt capP/EBeta
SYKStryker CorpB$118.1B31.810.79Compare
MDTMedtronic PLCA-$119.2B22.550.60Compare
CVSCVS Health CorpA-$124.3B25.300.57Compare
ELVElevance Health IncB+$89.95B17.690.65Compare
HCAHCA Healthcare IncB+$88.59B13.061.14Compare
ISRGIntuitive Surgical IncB-$130.7B41.861.48Compare
CICigna GroupB+$75.64B11.640.27Compare
BSXBoston Scientific CorpB$68.04B18.980.59Compare

You just read one holding. Clavix reads the whole portfolio.

Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.